Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study inThe Lancetconcluded the vaccine is 80% effective at preventing hospitalization due to complic...
Moderna announced positive results Tuesday from its phase 3 trial of anRSV vaccine for older adults, revealing plans to submit the vaccine for regulatory approval, which includes review by the US Food and Drug Administration, in the first half of 2023. There's no approved vaccine for RSV, or...
4.https://www.gsk.com/en-gb/media/press-releases/gsk-shares-positive-data-for-arexvy-its-respiratory-syncytial-virus-older-adult-vaccine-indicating-protection-over-two-rsv-seasons/ 5.https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/early-safety-data-rsv-vaccines-show-rare-guillain-...
1.各公司官网 2.Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort | BioSpace 3.其他公开资料 封面图来源:PIXABAY
4.https://www.gsk.com/en-gb/media/press-releases/gsk-shares-positive-data-for-arexvy-its-respiratory-syncytial-virus-older-adult-vaccine-indicating-protection-over-two-rsv-seasons/ 5.https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/early-safety-data-rsv-vaccines-show-rare-guillain-ba...
Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult ...
Given that RSV is a significant health concern, particularly in vulnerable populations like infants and the elderly, it would be important to make an RSV vaccine more accessible and more affordable. JS: It is likely that RSV vaccination will focus initially on the paediatric population, as epidemi...
Reference CDC. CDC recommends RSV vaccine for older adults. Published June 30, 2023. Accessed June 30, 2023.https://www.cdc.gov/media/releases/2023/s0629-rsv.html
11. US FDA Advisory Committee votes to support effectiveness and safety of GSK’s respiratory syncytial virus older adult vaccine candidate. Press release. GSK. March 1, 2023. Accessed May 15, 2023. https://www.gsk.com/en-gb/media/press-releases/us-fda-advisorycommittee-votes-to-support-effe...
"RSV represents a significant threat to younger adults with certain chronic conditions. After decades of vaccine research by the scientific community and Pfizer, we now have the opportunity to help alleviate the burden of RSV in this high-risk adult population," ...